[Eur Heart J 2020:doi:10.1093/eurheartj/ehaa190]
The authors of the above paper wish to inform readers that minor grammatical and style errors were found to be present in the originally published article version.
The title has been corrected from ‘Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin’ to ‘Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin’
The final paragraph has been corrected from the previous wording:
‘In 2020, there was a major outbreak of coronavirus infection. Unlike other coronavirus infections, which mainly cause pulmonary infections, this case of coronavirus infection was characterized by heart damage. The heart grew rapidly in a short period of time and quickly returns to normal after treatment. This type of clinical presentation has been previously reported to be rare. This case report is helpful in treating other similar patient. It is suggested that early glucocorticoid anti-inflammatory therapy and immunoglobulin therapy are of important value to this type of patient.’
It now reads:
‘Unlike other coronavirus infections, which mainly cause pulmonary infections, this case of coronavirus infection was characterized by heart damage. The cardiac chamber dimensions increased in a short period of time and quickly returned to normal after treatment. This case report is helpful in treating other similar patients. It is suggested that early glucocorticoid anti-inflammatory therapy and immunoglobulin therapy may be of important value to this type of patient.’
The paper has now been corrected online.